Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPM | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | SSBP4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | RBM10 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | SOCS7 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | PTBP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | PLEKHO1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |